(Q46295612)

21 December 2017

title

Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog (English)

1 reference

21 December 2017

author name string

Satyendra Kumar Rajput

1

1 reference

21 December 2017

Srinivasan Krishnamoorthy

2

1 reference

21 December 2017

Chandrasekhar Pawar

3

1 reference

21 December 2017

Navneet Kaur

4

1 reference

21 December 2017

Vikramdeep Monga

5

1 reference

21 December 2017

Chhuttan Lal Meena

6

1 reference

21 December 2017

Rahul Jain

7

1 reference

21 December 2017

Shyam S Sharma

8

1 reference

21 December 2017

publication date

13 November 2008

1 reference

21 December 2017

published in

Epilepsy Behavior

1 reference

21 December 2017

volume

14

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

48-53

1 reference

21 December 2017

Thyrotropin-releasing hormone analogs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Mechanisms of action of antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Pharmacological management of epilepsy: recent advances and future prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Systemic administration of kainic acid produces elevations in TRH in rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Protective effects of TRH and its stable analogue, RGH-2202, on kainate-induced seizures and neurotoxicity in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Thyrotropin-releasing hormone in the treatment of intractable epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Clinical study of oral administration of DN-1417, a TRH analog, in patients with intractable epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Thyrotropin-releasing hormone receptors -- similarities and differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Comparative metabolism and conformation of TRH and its analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Low affinity analogs of thyrotropin-releasing hormone are super-agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Synthesis and biology of new thyrotropin-releasing hormone (TRH) analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Valproate modulates TRH receptor, TRH and TRH-like peptide levels in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Synthesis and biological evaluations of brain-targeted chemical delivery systems of [Nva2]-TRH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Studies on the anticonvulsant effect of U50488H on maximal electroshock seizure in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Gamma-aminobutyric acid and glutamic acid receptors may mediate theophylline-induced seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Functional observational battery and motor activity in rats after single administration of two NHE 1 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

The biology of pro-thyrotropin-releasing hormone-derived peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Thyrotropin-releasing hormone increases GABA release in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Cerebrovascular effects of the TRH analogues pGlu-3-methyl-His-Pro amide and pGlu-Glu-Pro amide: a comparison with TRH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

Effects of thyrotropin-releasing hormone and its analogue, NS-3, on blood pressure, heart rate, and serum catecholamine levels in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2008.10.006

10.1016/J.YEBEH.2008.10.006

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017